Major moves in the pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind of activity.
How does one differentiate and obtain assets poised for clinical success in the next wave of deals?
Hosting and audience of 100+ ADC decision-makers from 60+ companies, the ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit drastically improve the hit-rate and alignment of ADC and radioligand partnership conversations, guaranteeing other attendees are valuable prospects looking to do deals.
What? ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
When? September 9-10, 2024
Where? Boston, MA
ACCESS EVENT GUIDE SPEAKER FACULTY CONTACT US
What can you expect?
- 100 + Attending companies developing innovative pipeline and platforms across ADCs, novel conjugates, and radiopharmaceuticals
- 20+ Hours of face-to-face networking with stakeholders across pharma, biotech, venture, intellectual property, and financial advice
- 16 + Company presentations showcasing new data and disruptive new technologies in early development
- 100% Alignment of interest to generate an unmissable number of conversations, partnerships and deals…. join us to find out!
For Pharma:
With representation from the key players, gather with other oncology large pharma innovation scouts and business development teams, looking to assess, qualify or understand infrastructure for due diligence on promising ADC or Radiopharmaceutical technologies, in scope and on strategy for external innovation.
For Biotech & Academic:
Creating a platform for face-to-face networking with targeted decision makers hyper-relevant to ADC and radiopharmaceutical investment, acquisition, licensing, and partnership; understanding what’s on scope and in strategy for buyers initiating business-to-business deals.
For Investors:
As ADCs and Radiopharmaceuticals continue to be the most exciting opportunity for investment, deal activity, and clinical progress in life sciences, capitalize on the world’s largest gathering of business decision makers in early development to identify strategic assets with promising returns.
Register now and cut through the noise of larger events to find the right partner faster!
